Cite
HARVARD Citation
Hermann, V. et al. (2019). First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study. Lupus science & medicine. 6 (1), p. . [Online].